Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar 15;11(3):554.
doi: 10.3390/antiox11030554.

Dietary Polyphenols as Therapeutic Intervention for Alzheimer's Disease: A Mechanistic Insight

Affiliations
Review

Dietary Polyphenols as Therapeutic Intervention for Alzheimer's Disease: A Mechanistic Insight

Syed Nasir Abbas Bukhari. Antioxidants (Basel). .

Abstract

Dietary polyphenols encompass a diverse range of secondary metabolites found in nature, such as fruits, vegetables, herbal teas, wine, and cocoa products, etc. Structurally, they are either derivatives or isomers of phenol acid, isoflavonoids and possess hidden health promoting characteristics, such as antioxidative, anti-aging, anti-cancerous and many more. The use of such polyphenols in combating the neuropathological war raging in this generation is currently a hotly debated topic. Lately, Alzheimer's disease (AD) is emerging as the most common neuropathological disease, destroying the livelihoods of millions in one way or another. Any therapeutic intervention to curtail its advancement in the generation to come has been in vain to date. Using dietary polyphenols to construct the barricade around it is going to be an effective strategy, taking into account their hidden potential to counter multifactorial events taking place under such pathology. Besides their strong antioxidant properties, naturally occurring polyphenols are reported to have neuroprotective effects by modulating the Aβ biogenesis pathway in Alzheimer's disease. Thus, in this review, I am focusing on unlocking the hidden secrets of dietary polyphenols and their mechanistic advantages to fight the war with AD and related pathology.

Keywords: amyloid; homeostasis; like curcumin; metal chelation; quercetin.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1
Figure 1
Different plausible Alzheimer’s disease mechanisms of Aβ aggregation, tau phosphorylation and aggregation, neurotransmitters imbalance, genetic defects, neuroinflammation, amyloid cross-seeding, vascular dysfunction, mitochondria dysfunction, and metal dysregulation [31]. “Reprinted from [31] “A mechanistic survey of Alzheimer’s disease” Biophysical Chemistry 2022, 281, 106735, (2022), with permission from Elsevier”.
Figure 2
Figure 2
Proposed Alzheimer’s disease Hypothesis and the mechanisms involved [32]. “Reprinted from “Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer’s disease. Journal of Controlled Release 2022, 343, 528–550, Taliyan, R.; Kakoty, V.; Sarathlal, K.C.; Kharavtekar, S.S.; Karennanavar, C.R.; Choudhary, Y.K.; Singhvi, G.; Riadi, Y.; Dubey, S.K.; Kesharwani, P. Copyright (2022), with permission from Elsevier”.
Figure 3
Figure 3
Classification of Dietary Polyphenols. Basic classification includes flavonoids (Anthocyanin, Anthoxanthin), stilbenes (Trans-resveratrol), phenolic acid (caffeic acid), diferuloylmethane, tannins (tannic acid).
Figure 4
Figure 4
Dietary Polyphenols’ Anti-Oxidative Mechanism. Mostly dietary polyphenols’ basic mechanism of action involves their role as antioxidant which can be achieved by modulating NRF2-KEAP1 antioxidant response pathway or through modulation of antioxidant enzyme, such as SOD (Superoxide Dismutase), Catalase and Glutathione peroxidase.
Figure 5
Figure 5
Dietary Polyphenols Influencing Amyloid Precursor Protein (APP) processing by modulating non-amyloidogenic pathway and amyloidogenic pathway.

Similar articles

Cited by

References

    1. Rakesh G., Szabo S.T., Alexopoulos G.S., Zannas A.S. Strategies for dementia prevention: Latest evidence and implications. Ther. Adv. Chronic Dis. 2017;8:121–136. doi: 10.1177/2040622317712442. - DOI - PMC - PubMed
    1. Breijyeh Z., Karaman R. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules. 2020;25:5789. doi: 10.3390/molecules25245789. - DOI - PMC - PubMed
    1. Barage S.H., Sonawane K.D. Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer’s disease. Neuropeptides. 2015;52:1–18. doi: 10.1016/j.npep.2015.06.008. - DOI - PubMed
    1. Baazaoui N., Iqbal K. A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation. J. Alzheimer’s Dis. 2018;62:1211–1218. doi: 10.3233/JAD-170839. - DOI - PMC - PubMed
    1. Soto-Faguás C.M., Sanchez-Molina P., Saura C.A. Loss of presenilin function enhances tau phosphorylation and aggregation in mice. Acta Neuropathol. Commun. 2021;9:162. doi: 10.1186/s40478-021-01259-7. - DOI - PMC - PubMed

LinkOut - more resources